基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Koen Degeling joined the Cancer Health Services Research unit as a Research Fellow in July 2019. After obtaining his Bachelor of Science degree and Master of Science degree (with distinction) in Industrial Engineering and Management, Koen started researching the use of advanced simulation techniques for modeling health and economic outcomes of personalized clinical pathways.
Based on his thesis ‘Simulation Modeling to Optimize Personalized Oncology’ (available for download here), Koen obtained his Doctoral degree with distinction from the University of Twente in 2019. His thesis provides practical and methodological guidance essential to the adoption of patient-level simulation techniques within health economics and health services research. Also, the thesis illustrates the potential of these methods to optimize clinical pathways and improve patient outcomes. Koen has been actively involved with the Professional Society for Health Economics and Outcomes Research (ISPOR, website). His absolute highlight within the society was chairing the ISPOR Student Network, representing approximately 5,000 students and over 120 chapters globally. In terms of research, Koen has contributed to international conferences of ISPOR and other societies as short course and workshop faculty, and as podium and poster presenter. With CHSR, Koen will advance his research on optimizing oncology care pathways using simulation models, including the use of genomics to inform treatment decisions and monitor treatment response. He will continue to explore the use of registry data to inform these simulation models, as he did using the Treatment of Advanced and Recurrent Colorectal Cancer (TRACC) registry during a four-month research visit at the unit in 2018. Also, he will further the guidance for applying patient-level simulation techniques to represent the complex dynamics of current clinical practice.
Based on his thesis ‘Simulation Modeling to Optimize Personalized Oncology’ (available for download here), Koen obtained his Doctoral degree with distinction from the University of Twente in 2019. His thesis provides practical and methodological guidance essential to the adoption of patient-level simulation techniques within health economics and health services research. Also, the thesis illustrates the potential of these methods to optimize clinical pathways and improve patient outcomes. Koen has been actively involved with the Professional Society for Health Economics and Outcomes Research (ISPOR, website). His absolute highlight within the society was chairing the ISPOR Student Network, representing approximately 5,000 students and over 120 chapters globally. In terms of research, Koen has contributed to international conferences of ISPOR and other societies as short course and workshop faculty, and as podium and poster presenter. With CHSR, Koen will advance his research on optimizing oncology care pathways using simulation models, including the use of genomics to inform treatment decisions and monitor treatment response. He will continue to explore the use of registry data to inform these simulation models, as he did using the Treatment of Advanced and Recurrent Colorectal Cancer (TRACC) registry during a four-month research visit at the unit in 2018. Also, he will further the guidance for applying patient-level simulation techniques to represent the complex dynamics of current clinical practice.
Research Interests
Papers共 66 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Value in Health (2024)
The Journal of Molecular Diagnosticsno. 8 (2024): 673-684
S. Banks, W. Hong,K. Degeling,J. Shapiro,B. Thomson, H.S. Ko,S. Ananda,A. Jalali,Y.H. To,B. Loveday,S.-A. McLachlan,B. Knowles,
ESMO Real World Data and Digital Oncology (2024): 100022
Frontiers in Pharmacology (2023): 1255021-1255021
M.J.G. Bond,M. van Smeden,K. Degeling,C. Cremolini, H.J.E-V. Schmoll,D. Rossini, S. Ibach,M. Koopman,C.J.A. Punt,A.M. May,J.J. Kwakman
Annals of Oncology (2023): S438-e2400037
Annals of Oncology (2023): S924-S924
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023): 110-111
Cited0Views0Bibtex
0
0
FRONTIERS IN PHARMACOLOGY (2023): 1249998
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn